A Hungarian university may develop and start mass production of a miracle drug using the sweet woodworm, a Nobel Prize-winning herb.

Nutraceuticals in India are gaining popularity due to rising health awareness, an increase in lifestyle diseases, and a shift ...

Teva Pharmaceutical Industries Limited (NYSE:TEVA – Free Report) by 15.0% during the 4th quarter, according to its most ...

Maintaining a healthy urinary flow is essential for overall well-being, particularly as men age. As research in the field of ...

In a world where men increasingly seek ways to enhance their vitality, performance, and overall well-being, natural ...

CHICAGO - Cosmos Health Inc. (NASDAQ:COSM), a global healthcare group with a market capitalization of $15.18 million, has announced a new 10-year contract manufacturing agreement through its ...

Company had $98.8 million in cash as of December 31, 2024; existing cash expected to fund planned operations into the first quarter of ...

Neurocrine Biosciences, Inc.’s NBIX share price has dipped by 18.53%, which has investors questioning if this is right time ...

The Trump Administration's 10% tariff on all Chinese imports took effect on Feb. 4. Many unknowns remain, but Americans will ...

Learn more about whether Biogen Inc. or Neurocrine Biosciences, Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.

Supernus Pharmaceuticals' FDA approval for ONAPGO in Parkinson's Disease offers optimism despite past challenges, with a ...